Evidence map›Paper›PMID 25478326›Full record

ReviewFrontiers in oncology2014

The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries.

C Norman Coleman, Silvia C Formenti, Tim R Williams, Daniel G Petereit, Khee C Soo, John Wong, Nelson Chao, Lawrence N Shulman, Surbhi Grover, Ian Magrath and 10 more

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

C Norman ColemanInternational Cancer Expert Corps , Chevy Chase, MD , USA.
Silvia C FormentiNew York University Medical School , New York, NY , USA.
Tim R WilliamsLynn Cancer Institute at Boca Raton Regional Hospital , Boca Raton, FL , USA.
Daniel G PetereitAmerican Indian "Walking Forward" Program , Rapid City, SD , USA.
Khee C SooNational Cancer Center , Singapore , Singapore.
John WongNational University Cancer Institute, National University of Singapore , Singapore , Singapore.
Nelson ChaoDivision of Hematologic Malignancies and Cellular Therapy, BMT and Global Cancer, Duke Cancer Institute, Duke University , Durham, NC , USA.
Lawrence N ShulmanDana-Farber Cancer Institute, Harvard Medical School , Boston, MA , USA.
Surbhi GroverDepartment of Radiation Oncology, Abramson Cancer Center, University of Pennsylvania , Philadelphia, PA , USA.
Ian MagrathInternational Network for Cancer Treatment and Research , Brussels , Belgium.
Stephen HahnDepartment of Radiation Oncology, Abramson Cancer Center, University of Pennsylvania , Philadelphia, PA , USA.
Fei-Fei LiuDepartment of Radiation Oncology, Radiation Medicine Program, Princess Margaret Cancer Centre, University of Toronto , Toronto, ON , Canada.
Theodore DeWeeseDepartment of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University , Baltimore, MD , USA.
Samir N KhleifCancer Center, Georgia Regents University , Augusta, GA , USA.
Michael SteinbergDepartment of Radiation Oncology, University of California Los Angeles , Los Angeles, CA , USA.
Lawrence RothInternational Cancer Expert Corps , Chevy Chase, MD , USA.
David A PistenmaaInternational Cancer Expert Corps , Chevy Chase, MD , USA.
Richard R LoveInternational Cancer Expert Corps , Chevy Chase, MD , USA ; International Breast Cancer Research Foundation , Madison, WI , USA.
Majid MohiuddinRadiation Oncology Consultants, Ltd. , Park Ridge, IL , USA.
Bhadrasain VikramRadiation Research Program, National Cancer Institute , Bethesda, MD , USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing burden of non-communicable diseases including cancer in low- and lower-middle income countries (LMICs) and in geographic-access limited settings within resource-rich countries requires effective and sustainable solutions. The International Cancer Expert Corps (ICEC) is pioneering a novel global mentorship-partnership model to address workforce capability and capacity within cancer disparities regions built on the requirement for local investment in personnel and infrastructure. Radiation oncology will be a key component given its efficacy for cure even for the advanced stages of disease often encountered and for palliation. The goal for an ICEC Center within these health disparities settings is to develop and retain a high-quality sustainable workforce who can provide the best possible cancer care, conduct research, and become a regional center of excellence. The ICEC Center can also serve as a focal point for economic, social, and healthcare system improvement. ICEC is establishing teams of Experts with expertise to mentor in the broad range of subjects required to establish and sustain cancer care programs. The Hubs are cancer centers or other groups and professional societies in resource-rich settings that will comprise the global infrastructure coordinated by ICEC Central. A transformational tenet of ICEC is that altruistic, human-service activity should be an integral part of a healthcare career. To achieve a critical mass of mentors ICEC is working with three groups: academia, private practice, and senior mentors/retirees. While in-kind support will be important, ICEC seeks support for the career time dedicated to this activity through grants, government support, industry, and philanthropy. Providing care for people with cancer in LMICs has been a recalcitrant problem. The alarming increase in the global burden of cancer in LMICs underscores the urgency and makes this an opportune time fornovel and sustainable solutions to transform cancer care globally.

Indexed as

cancerglobal healthhealth disparitiesnon-communicable diseasesunderserved

Identifiers

PMID25478326
PMCPMC4237042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.